trial · primary record
Adavosertib
Advanced Lymphoma
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 6452 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Objective response rate (ORR) |
| Registry ID | NCT02465060 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:05.977Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02465060
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.